Transmitted drug resistance to rilpivirine among antiretroviral-naïve patients living with HIV from northern Poland

INTRODUCTION: Rilpivirine (RPV) is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) that was recently approved for the treatment of antiretroviral-naïve individuals with HIV-1 viral load of <100,000 copies/ml. As transmission of the drug resistance mutations to this NNRT...

Descripción completa

Detalles Bibliográficos
Autores principales: Parczewski, Miłosz, Urbańska, Anna, Maciejewska, Katarzyna, Witak-Jȩdra, Magdalena, Leszczyszyn-Pynka, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991831/
https://www.ncbi.nlm.nih.gov/pubmed/24746180
http://dx.doi.org/10.7448/IAS.17.1.18929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991831/
https://www.ncbi.nlm.nih.gov/pubmed/24746180
http://dx.doi.org/10.7448/IAS.17.1.18929

Ejemplares similares